We believe that Stanley Works currently represents a good risk/reward opportunity for longer term value investors.

It is possible that pharmaceutical group stock momentum could carry (Lilly) higher, but we believe the risk/reward warrants a neutral rating.

It's too much risk for too little reward.

With payrolls so close, people are looking at risk/reward and deciding to be safe.

From a risk-reward stand point, there's very limited down side here. You have to remember many of these oil companies are stocks are basically at 12-month lows. They were at these levels when oil prices were at $11. What you have right here, it is a momentum market....[and] once you start to see the oil price consolidate, you come in in full force and frankly, you can start to pick some of these names up right now.

The board continues to believe that the price offered by Carnival does not fairly reward shareholders for the value that would be created by Carnival and its shareholders from the integration of P&O Princess into Carnival,